Cocaine and alcohol interactions in the rat: Contribution of cocaine metabolites to the pharmacological effects

Journal of Pharmaceutical Sciences

Volumn 88, Issue 4, 1999, Pages 468-474

  Wei Jian, Pan ^a   Hedaya, Mohsen A ^a,b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b TANTA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZOYLECGONINE; COCAINE; DRUG METABOLITE; HOMOCOCAINE; NORCOCAINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPARTMENT MODEL; DRUG ALCOHOL INTERACTION; DRUG HALF LIFE; DRUG METABOLISM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PHARMACODYNAMICS; RAT;

EID: 0345148795     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980283h     Document Type: Article

References (28)

1. Stewart, D. J.; Inaba, T.; Lucassen, M.; Kalow, W. Cocaine Metabolism: Cocaine and Norcocaine Hydrolysis by Liver and Serum Esterases. Clin. Pharmacol. Ther. 1979, 25, 464-468.
2. Dean, R. A.; Christian, C. D.; Sample, R. H.; Bosron, W. F. Human Liver Cocaine Esterases: Ethanol-Mediated Formation of Ethylcocaine. FASEB J. 1991, 5, 2735-2739.
3. Kloss, M. W.; Rosen, G. M.; Rauckman, E. J. N-Demethylation of Cocaine to Norcocaine. Evidence for Participation by Cytochrome P-450 and FAD-Containing Monooxygenase. Mol. Pharmacol. 1983, 23, 482-485.
4. Roberts, S. M.; Harbison, R. D.; James, R. C. Human Microsomal N-oxidative Metabolism of Cocaine. Drug Metab. Dispos. 1991, 19, 1046-1051.
5. Poet, T. S.; McQueen, C. A.; Halpert, J. R. Participation of Cytochromes P4502B and P4503A in Cocaine Toxicity in Rat Hepatocytes. Drug Metab. Dispos. 1996, 24, 74-80.
6. Johanson, C. E.; Fischman, M. W. The Pharmacology of Cocaine Related to Its Abuse. Pharmacol. Rev. 1989, 41, 3-52
7. Ritz, M. C.; Lamb, R. J.; Goldberg, S. R.; Kuhar, M. J. Cocaine Receptors on Dopamine Transporters Are Related to Self-administration of Cocaine. Science 1987, 237, 1219-1223.
8. Roberts, D. C.; Koob, G. F.; Klonoff, P.; Fibiger, H. C. Extinction and Recovery of Cocaine Self-Administration Following 6-Hydroxydopamine Lesions of the Nucleus Accumbens. Pharmacol. Biochem. Behav. 1980, 12, 781-787.
9. Marzuk, P. M.; Tardiff, K.; Leon, A. C.; Hirsch, C. S.; Stajic, M.; Portera, L.; Hartwell, N.; Iqbal, M. I. Fatal Injuries after Cocaine Use as a Leading Cause of Death Among Young Adults in New York City. N. Engl. J. Med. 1995, 332, 1753-1757.
10. Crumb, W. J., Jr.; Clarkson, C. W. Characterization of the Sodium Channel Blocking Properties of the Major Metabolites of Cocaine in Single Cardiac Myocytes. J. Pharmacol. Exp. Ther. 1992, 261, 910-917.
11. Erzouki, H. K.; Baum, I.; Goldberg, S. R.; Schindler, C. W. Comparison of the Effects of Cocaine and Its Metabolites on Cardiovascular Function in Anesthetized Rats. J. Cardiovasc. Pharmacol. 1993, 22, 557-563.
12. Schuelke, G. S.; Konkol, R. J.; Terry, L. C.; Madden, J. A. Effect of Cocaine Metabolites on Behavior: Possible Neuroendocrine Mechanisms. Brain Res. Bull. 1996, 39, 43-48.
13. Shuster, L.; Garhart, C. A.; Powers, J.; Grunfeld, Y.; Kanel, G. Hepatotoxicity of Cocaine. NIDA Res. Monogr. 1988, 88, 250-275
14. Jatlow, P.; Elsworth, J. D.; Bradberry, C. W.; Winger, G.; Taylor, J. R.; Russell, R.; Roth, R. H. Cocaethylene: A Neuropharmacologically Active Metabolite Associated with Concurrent Cocaine-Ethanol Ingestion. Life Sci. 1991, 48, 1787-1794.
15. Farre, M.; Torre, R.; Llorente, M.; Lamas, X.; Ugena, B.; Segura, J.; Cami, J. Alcohol and Cocaine Interactions in Humans. J. Pharmacol. Exp. Ther. 1993, 266, 1364-1373.
16. Hearn, W. L.; Flynn, D. D.; Hime, G. W.; Rose, S.; Cofino, J. C.; Mantero-Atienza, E.; Wetli, C. V.; Mash, D. C. Cocaethylene: A Unique Cocaine Metabolite Displays High Affinity for the Dopamine Transporter. J. Neurochem. 1991, 56, 698-701.
17. Pan, W. J.; Hedaya, M. A. An Animal Model for Simultaneous Pharmacokinetic/Pharmacodynamic Investigations: Application to Cocaine. J. Pharmacol. Toxicol. Meth. 1998, 39, 1-8.
18. Pan, W. J.; Hedaya, M. A. Cocaine and Alcohol Interactions in the Rat: Effect on Cocaine Pharmacokinetics and Pharmacodynamics. J. Pharm. Sci. 1999, 88, 459-467.
19. Pan, W. J.; Hedaya, M. A. Sensitive and Specific High-Performance Liquid Chromatographic Assay with Ultraviolet Detection for the Determination of Cocaine and Its Metabolites in Rat Plasma. J. Chromatogr. B Biomed. Sci. Appl. 1997, 703, 129-138.
20. Gibaldi, M.; Perrier, D. Pharmacokinetics, 2nd ed.; Marcel Dekker: New York, 1982, pp 45-111.
21. Houston, J. B. Drug Metabolite Kinetics. Pharmacol. Ther. 1982, 15, 521-552.
22. Sharma, A.; Jusko, W. J. Characterization of Four Basic Models of Indirect Pharmacodynamic Responses. J. Pharmacokinet. Biopharm. 1996, 24, 611-635.
23. Krzyzanski, W.; Jusko, W. J. Mathematical Formalism for the Properties of Four Basic Models of Indirect Pharmacodynamic Responses. J. Pharmacokinet. Biopharm. 1997, 25, 107-123.
24. Xu, Y. Q.; Crumb, W. J. Jr.; Clarkson, C. W. Cocaethylene, A Metabolite of Cocaine and Ethanol, Is a Potent Blocker of Cardiac Sodium Channels. J. Pharmacol. Exp. Ther. 1994, 277, 319-325.
25. th ed.; Klaassen, C. D., Ed.; McGraw-Hill: New York, 1996; pp 113-186.
26. Boelsterli, U. A.; Göldlin, C. Biomechanisms of Cocaine-Induced Hepatocyte Injury Mediated by the Formation of Reactive Metabolites. Arch. Toxicol. 1991, 65, 351-360.
27. Smith, A. C.; Freeman, R. W.; Harbison, R. D. Ethanol Enhancement of Cocaine-Induced Hepatotoxicity. Biochem. Pharmacol. 1981, 30, 453-458.
28. Boelsterli, U. A.; Lanzotti, A.; Göldlin, C.; Oertle, M. Identification of Cytochrome P-450IIB1 as A Cocaine-Bioactivating Isoform in Rat Hepatic Microsomes and in Cultured Rat Hepatocytes. Drug Metab. Dispos. 1992, 20, 96-101.